Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-17

FDA Approved: MIGLUSTAT — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' miglustat original-application product (generic miglustat). It is indicated for Niemann-Pick disease type C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Miglustat (miglustat)

Snippet

ORIG AP for MIGLUSTAT (MIGLUSTAT)